Chemistry: molecular biology and microbiology – Virus or bacteriophage – except for viral vector or...
Reexamination Certificate
2005-03-01
2005-03-01
Stucker, Jeffrey (Department: 1648)
Chemistry: molecular biology and microbiology
Virus or bacteriophage, except for viral vector or...
Reexamination Certificate
active
06861244
ABSTRACT:
The invention relates to nasal or oral administration of a compound containing inactivated influenza virus antigen and aluminum as adjuvant for the prophylaxis of influenza virus infections. Said vaccine is especially suitable for inducing a mucosal IgA immune response and systemic IgG immune response.
REFERENCES:
patent: 4981782 (1991-01-01), Judd et al.
patent: 5136019 (1992-08-01), Judd et al.
patent: 5243030 (1993-09-01), Judd et al.
patent: 5976552 (1999-11-01), Volvovitz
patent: 6635246 (2003-10-01), Barrett et al.
patent: WO9749423 (1931-12-01), None
patent: WO9419013 (1994-09-01), None
patent: WO9615231 (1996-05-01), None
patent: WO9640290 (1996-12-01), None
patent: WO9924068 (1999-05-01), None
patent: WO0015251 (2000-03-01), None
Waldman, Nature 218: 594-595 (1968).
Wood, Journal of Biological Standardization 5: 237-247 (1977).
Avtushenko et al., Journal of Biotechnology 44: 21-28 (1996).
Belshe et al., New England Journal of Medicine 338(20): 1405-1412 (1998).
Chen et al., Current Topics in Microbiology and Immunology 146: 101-106 (1989).
Couch et al., Journal Infectious Diseases 176: 38-44 (1997).
Davenport et al., The Journal of Immunology 100(5): 1139-1140 (1968).
De Hann et al., Vaccine 13(2): 155-162 (1995).
Komase et al., Vaccine 16(2/3): 248-254 (1998).
Liew et al., Eur. J. Immunol. 14: 350-356 (1984).
Oka et al., Vaccine 8: 573-576 (1990).
Oka et al., Vaccine 12(14): 1255-1258 (1994).
Palmer et al., A Procedural Guide to the Performance of Rubella Hemagglutination-Inhibition Tests. U.S. Dept. of Health, Education, and Welfare, Immunology Series No. 2 Revised, pp. 25-62 (1977).
Tamura et al., The Journal of Immunology 149(3): 981-988 (1992).
Barrett Noel
Dorner Friedrich
Gerencer Marijan
Kistner Otfried
Baxter Healthcare S.A.
Heller Ehrman White & McAuliffe LLP
Stucker Jeffrey
LandOfFree
Inactivated influenza virus vaccine for nasal or oral... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inactivated influenza virus vaccine for nasal or oral..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inactivated influenza virus vaccine for nasal or oral... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3449087